PITYRIASIS ROSEA GILBERT FAMILIAL CASE REVIEW
PDF

How to Cite

Gigineishvili, K., Eliava, M., & Katsitadze, A. (2023). PITYRIASIS ROSEA GILBERT FAMILIAL CASE REVIEW. Collection of Scientific Works of Tbilisi State Medical University, 56, 43–45. Retrieved from https://journals.4science.ge/index.php/CSW/article/view/2270

Abstract

Pityriasis rosea Gilbert is an inflammatory, self limited dermatosis, that is characterized by an oval and circular, maculopapular and erythematosquamous rash. The exact cause is still unknown, but in a recent period, significant attention is devoted to the infective theory, which is probably related to our clinical report. We present a familial case of a 26-year-old patient, with multiple rashes on his upper extremities and trunk area. During the inspection of the patient, it was discovered that his general condition was satisfactory. Body temperature was within normal limits. Lymph nodes weren’t palpable. During the examination of visible mucous membranes, pathological changes weren’t observed. The eruptions on the body were numerous, symmetric, oval and circular, small sized plaques with fine scale on the lower part of the body, there wasn’t spread of lesions on lower extremities. During a survey of the patient, it was found that his wife also had a similar rash. A potassium hydroxide examination of skin scrapings for fungal elements was negative. Patient and his wife were diagnosed with Pityriasis rosea Gilbert’s familial case, probably caused by virus agent. Recommendations were given to the patients and proper treatment was prescribed.

PDF

References

https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020

Zeinab Abdelrahman, Mengyuan Li and XiaoshengWang, Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.Front. Immunol., 11 September 2020;

https://www.worldometers.info/coronavirus/ -20.12.2020;

Risk factors and risk groups of Covid-19; European Center for Disease Control and Prevention, https://www.ecdc.europa.eu/en/covid-19/latest-evidence/epidemiology .

Nina Vindegaard and Michael EriksenBenros. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Elsevier Public Health collection, May, 2020.

Claudia Carvalho-Schneider, Emeline Laurent,AdrienLemaignen et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clinical Microbiology and Infections. October, 2020.

Julia Mackolil, JobyMackolil, Addressing psychosocial problems associated with the COVID-19 lockdown. Asian Journal of Psychiatry 51 (2020)

Calliope Holingue, PhD, MPH; Luther G. Kalb, PhD; Kira E. Riehm, MSc; Daniel Bennett, PhD; Arie Kapteyn, PhD; Cindy B. Veldhuis, PhD; Renee M. Johnson, PhD, MPH; M. Daniele Fallin, PhD; FraukeKreuter, PhD; Elizabeth A. Stuart, PhD; Johannes Thrulet all. Mental Distress in the United States at the Beginning of the COVID-19 Pandemic. Am J Public Health. 2020;110(11):1628-1634.48

Nora D. Volkow. Collision of the COVID-19 and Addiction Epidemics. Annals of Internal Medicine.April, 2020.

SimonaZaami, Enrico Marinelli and Maria Rosaria Varì.New Trends of Substance AbuseDuring COVID-19 Pandemic: AnInternational Perspective.Frontiers in Psychiatry, 16 July 2020.

Mahua Jana Dubey, RitwikGhosh, SubhamChatter jee, PayelBiswas,SubhankarChatterjee, Souvik Dubey. COVID-19 and addiction. Diabetes &Metabolic Syndrome: Clinical Research &Reviews. 14 (June) 2020.

Sujita Kumar Kar, Pawan Sharmaet al. COVID-19 pandemic and addiction: Current problems and future concerns. Asian Journal of Psychiatry, 51. Elsevier. March 2020.

Downloads

Download data is not yet available.